Express Scripts
Express Scripts Holding Company is a pharmacy benefit management organization. It was the 25th-largest in the United States by total revenue as well as the largest pharmacy benefit management organization in the United States. Express Scripts had 2016 revenues of $100.752 billion. Since December 20, 2018, the company has been a subsidiary of Cigna.
The term "scripts" refers to the widely used clipped version of prescription.
Headquartered in Greater St. Louis within unincorporated North St. Louis County, Missouri, Express Scripts provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies. One of its largest clients is the United States Department of Defense's Tricare program.
Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies.
The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense medications for chronic long-term diseases, such as diabetes or heart disease, directly to members by home delivery.
On March 7, 2018, it was announced that Cigna would buy Express Scripts in a $67 billion deal.
On August 24, 2018, the shareholders of Cigna and Express Scripts approved the $67 billion deal. The deal closed on December 20, 2018 at $54 billion, allowing Cigna to start offering new Express Scripts products to its corporate health insurance customers in 2019.
History
Founding
Express Scripts began in 1986 in St. Louis County, Missouri as a result of a joint venture between a retail chain of more than 79 pharmacies and Sanus Corp. Health Systems.Sanus traces its history to Bradford Systems and Administrative Services which was founded in Boston in 1968. Bradford had a contract for computer processing of Medicare and Medicaid payments. It was acquired in 1981 by McDonnell-Douglas through its McDonnell Automation Company subsidiary for $11.5 million.
In 1983 two of McDonnell Douglas principals Joseph T. Lynaugh and McAuto project manager of the Bradford takeover and Howard L. Waltman a long time Bradford employee formed the Sanus Corporation with substantial investments and ownership from McDonnell Douglas including a McDonnell Douglas whole ownership of the St. Louis office. General American Life Insurance Company invested in the larger parent based in New York. Sansa was a health maintenance organization and it merged with the General America Life Insurance preferred provider organization. Sanus rapidly grew and by 1986 it had 200,000 clients and $100 million in revenue operated in the St. Louis, Dallas, Fort Worth, Houston, and Washington, D.C. markets
It created a subsidiary called GenCare to fill prescriptions. In late 1986 it announced a deal with St. Louis based pharmacy Medicare-Glaser for fulfilling prescriptions that would be 50-50 split ownership between Sanus and Medicare-Glaser called Express Scripts. Initial plans called for Missouri and Illinois clients to get their prescriptions at the Medicare-Glaser brick and mortar pharmacies while those in other cities could get their prescriptions via mail order—an innovation at the time. The initial report of the creation said that Charles H. Ridings, formerly in charge of McDonnell Douglas mergers and acquisitions, was named the first chief executive.
Sanus remained the dominant early insurance customer but Express Scripts began marketing to other providers. With increased investment by New York Life Sansus change its name to NYL Cares and in 1998 was sold to Aetna for $1.05 billion.
The Glaser Drug Company sold to chain SupeRx in 1989 for $18.2 million. SupeRX declared bankruptcy and all stores closed in 1991 after Walgreens acquired the pharmacy records. SupeRX's loan to buy the chain had been financed by Lincoln Savings and Loan Association. Morris Glaser had founded the company on October 1, 1924. In 1959 Glaser opened discount pharmacies which would be called Medicare Pharmacy. The discount pharmacies were design to be resemble a doctor waiting room and were only about 800 to 1,000 square feet which focused just on the prescriptions. The two companies although sharing the same name operated separately, peaking at 100 stores.
General America, which had been a private St. Louis-based insurance since 1933, was acquired by MetLife for $1.2 billion in 1999. General America had run into financial problems and had said it could not pay back $6.8 billion in short term bonds to investors.
1989-1999
Express Scripts was purchased by New York Life Insurance Company in 1989 and became a publicly traded company in 1992. In 1993, Express Scripts signed on both FHP International and Maxicare Health Care and corporate clients Lockheed, Service Merchandise, and Ingersoll-Rand. In 1994, the company expanded its services by adding workers’ compensation prescription services and reinsurance. In 1994, the company announced a two-for-one stock split, and in 1996 established Express Scripts Canada. The same year, the company began the annual Drug Trend Report and launched the Outcomes Symposium Conference.In April 1998, Express Scripts acquired ValueRx, the PBM business of Columbia/HCA Healthcare Corp. The following year, in April 1999, the company purchased Diversified Pharmaceutical Services from SmithKline Beecham Corp for $700 million. That same year, the company purchased stock in PlanetRx.com. This partnership offered members options for purchasing prescriptions and over-the-counter health products online.
2000-2010
In 2000, the company had to write off its $165 million relationship with PlanetRx.com when the startup experienced financial difficulties. In 2001, Express Scripts partnered with Merck-Medco and Advance PSC to form RxHub LLC.In late December 2006, Express Scripts made a proposal to purchase Caremark. Express Scripts lost the race to acquire Caremark to CVS Corporation, which became CVS/Caremark Corporation on March 22, 2007.
In October 2007, Express Scripts acquired ConnectYourCare, and now handles FSA, HRA and HSA accounts for companies such as Suntrust, Zions Bancorporation and Allegis. However, Express Scripts divested ConnectYourCare in August 2012.
On April 13, 2009, it was announced that Indianapolis-based WellPoint had agreed to sell its NextRx subsidiaries for $4.675 billion to Express Scripts. Express Scripts closed the transaction in December 2009.
2010-present
In April 2012, Express Scripts completed a $29.1 billion acquisition of Medco Health Solutions. The Federal Trade Commission gave formal approval on April 2, 2012 after an anti-trust investigation. The acquisition positioned Express Scripts Holding Co. as the largest pharmacy benefit manager, filling 1.4 billion annual prescriptions.In 2017, Express Scripts launched Inside Rx, a partially owned subsidiary that provides discounts on medications for the uninsured and underinsured. In July 2017, Express Scripts purchased myMatrixx, a workers' compensation pharmacy benefits company based in Tampa, for $250 million.
In October 2017, Express Scripts lost its biggest client, Anthem, which said it would not renew the PBM contract in 2019 and would instead use CVS Health. Anthem alleged in court filings that Express had overcharged it by $3 billion. Anthem said that it would launch its own competing PBM service, IngenioRx. The battle between the two companies in 2017 caused Express Scripts stock to drop by nearly a third. Express Scripts announced its acquisition of eviCore in October 2017. The $3.6 billion deal closed that December. In November 2017, Express Scripts announced it was divesting United BioSource Corp., its pharmaceutical support business. UBC was sold to Avista Capital Partners.
In March 2018, Cigna, which earlier was blocked by courts from being acquired by Anthem, announced a $67 billion deal to acquire Express Scripts. The Express Scripts acquisition would be the last major deal involving the country's largest PBMs. In 2017, CVS Health announced a merger with Aetna, completing in November 2018. The takeover of PBMs have drawn regulator resistance because of fears they foster an anti-competitive environment. Insurance companies have charged that the PBM model has contributed to high drug prices because PBMs take a commission on each transaction.
Express Scripts has 30,000 employees worldwide. The company volunteers with local Blessings in a Backpack organizations.
In December 2018, it was reported that Walmart and Express Scripts extended their network agreement to give Express Scripts' clients access to Walmart's prescription services.
In December 2019, Express Scripts entered into a three-year partnership with Prime Therapeutics.
In February 2020, Dave Queller was named president of Express Scripts and Brian Seiz was named president of Express Scripts' pharmacy division.
Finances
For the fiscal year 2017, Express Scripts reported earnings of US$4.517 billion, with an annual revenue of US$100.065 billion, a decline of 0.2% over the previous fiscal cycle. Express Scripts shares traded at over $64 per share, and its market capitalization was valued at over US$53.6 billion in October 2018.| Year | Revenue in mil. USD$ | Net income in mil. USD$ | Total Assets in mil. USD$ | Price per Share in USD$ | Employees |
| 2005 | 16,188 | 400 | 5,494 | 13.65 | |
| 2006 | 21,563 | 474 | 5,108 | 19.49 | |
| 2007 | 21,824 | 568 | 5,256 | 25.40 | |
| 2008 | 21,941 | 776 | 5,509 | 32.77 | |
| 2009 | 24,722 | 828 | 11,931 | 33.61 | |
| 2010 | 44,973 | 1,181 | 10,558 | 48.71 | |
| 2011 | 46,128 | 1,276 | 15,607 | 50.92 | |
| 2012 | 93,714 | 1,313 | 58,111 | 55.87 | |
| 2013 | 104,099 | 1,845 | 53,548 | 61.67 | 29,975 |
| 2014 | 100,887 | 2,008 | 53,748 | 73.66 | 29,500 |
| 2015 | 101,752 | 2,476 | 53,243 | 86.01 | 25,900 |
| 2016 | 100,288 | 3,404 | 51,745 | 72.98 | 25,600 |
| 2017 | 100,065 | 4,517 | 54,256 | 64.41 | 26,600 |
World headquarters
Express Scripts is headquartered within Greater St. Louis in North St. Louis County, Missouri.In 2007, the company became the first and only Fortune 500 company to open a headquarters on a college campus when it opened its headquarters at 1 Express Way on the north edge of the University of Missouri–St. Louis north of University Place Drive and south of Interstate 70. A second headquarters building adjoining the original one opened in 2008. Three additional structures have been added to the NorthPark development on the north side of I-70 including an Office and Data Center, Tech and Innovation Center, and Operations Center. The area north of I-70 is separate from the university. In 2018 the majority of the 5,000 St. Louis Express Scripts employees work in the complex.
Timothy Wentworth, CEO of Express Scripts at the time of the move, was an UMSL graduate. Express Scripts, which rather owns both its headquarters and nearby office buildings, received substantial tax breaks. Since the move the company has been an active partner with the university including contributing money to renovate the computer sciences building, raising funds for building projects, sponsoring a pre-collegiate bridge program for high school students and sponsoring a small business incubator.
Express Scripts throughout its entire history has been in St. Louis County, Missouri rather than the City of St. Louis. It was originally headquartered in Maryland Heights, Missouri, and its current headquarters is about 4 miles west of the St. Louis city limits and its two building headquarters campus is actually spread across three jurisdictions. The entrance to the main building is located in Cool Valley, Missouri. The southeast portion of the campus is in Bellerive, Missouri and the southwest corner of the two-building complex is in unincorporated St. Louis County. The three buildings north of I-70 are in Berkeley, Missouri.
Chief executives
- Howard L. Waltman
- Barrett A. Toan
- George Paz
- Tim Wentworth
Drug Trend Report